What is the equity of Adimmune this year?
Adimmune has equity of 5.47 B TWD this year.
Adimmune Equity 2024
Adimmune Equity
5.47 B TWD
Ticker
4142.TW
ISIN
TW0004142005
In 2024, Adimmune's equity was 5.47 B TWD, a -10.6% increase from the 6.12 B TWD equity in the previous year.
Adimmune Aktienanalyse
What does Adimmune do?
Adimmune ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Adimmune's Equity
Adimmune's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Adimmune's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Adimmune's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Adimmune's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Adimmune’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Adimmune stock
What was the equity of Adimmune compared to the previous year?
The equity of Adimmune has increased/decreased by -10.6% decreased compared to the previous year.
What impact does a high equity have on investors of Adimmune?
A high equity is advantageous for investors of Adimmune as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Adimmune?
A low equity can be a risk for investors of Adimmune, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Adimmune affect the company?
An increase in equity of Adimmune can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Adimmune affect the company?
A reduction in equity of Adimmune can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Adimmune?
Some factors that can affect the equity of Adimmune include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Adimmune so important for investors?
The equity of Adimmune is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Adimmune take to change the equity?
To change equity, Adimmune can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Adimmune pay?
Over the past 12 months, Adimmune paid a dividend of 0.5 TWD . This corresponds to a dividend yield of about 2.53 %. For the coming 12 months, Adimmune is expected to pay a dividend of -0.25 TWD.
What is the dividend yield of Adimmune?
The current dividend yield of Adimmune is 2.53 %.
When does Adimmune pay dividends?
Adimmune pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Adimmune?
Adimmune paid dividends every year for the past 0 years.
What is the dividend of Adimmune?
For the upcoming 12 months, dividends amounting to -0.25 TWD are expected. This corresponds to a dividend yield of -1.29 %.
In which sector is Adimmune located?
Adimmune is assigned to the 'Health' sector.
Wann musste ich die Aktien von Adimmune kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Adimmune from 10/13/2021 amounting to 0.5 TWD, you needed to have the stock in your portfolio before the ex-date on 9/14/2021.
When did Adimmune pay the last dividend?
The last dividend was paid out on 10/13/2021.
What was the dividend of Adimmune in the year 2023?
In the year 2023, Adimmune distributed 0 TWD as dividends.
In which currency does Adimmune pay out the dividend?
The dividends of Adimmune are distributed in TWD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Adimmune
Our stock analysis for Adimmune Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Adimmune Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.